Premalignant alteration assessment in liver-like tissue derived from embryonic stem cells by aristolochic acid I exposure

Oncotarget

Volumn 7, Issue 48, 2016, Pages 78872-78882

  Li, Tong ^a   Jin, Ke ^a   Zhu, Dan Yan ^a   Li, Lu ^a   Mao, Zheng Rong ^b   Wu, Bo Wen ^a   Wang, Yi Fan ^a   Pan, Zong Fu ^a   Li, Lan Juan ^c   Xiang, Chun Sheng ^c   Su, Kun Kai ^c   Lou, Yi Jia ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Aristolochic acid I; C Myc Lin28B; Paracrine IL 6; Premalignant assessment; Stem cell derived liver like tissue

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; ARISTOLOCHIC ACID; ARISTOLOCHIC ACID I; CYTOKERATIN 19; CYTOKERATIN 7; INTERLEUKIN 6; LIN28B PROTEIN; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; ONCOPROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; ALBUMINOID; DNA BINDING PROTEIN; INTERLEUKIN-6, MOUSE; KRT2-7 PROTEIN, MOUSE; LIN28B PROTEIN, MOUSE; MYC PROTEIN, MOUSE; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEDIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; IN VITRO STUDY; LIVER CANCER; LIVER CELL; LIVER CELL CARCINOMA; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHENOTYPE; PRECANCER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; CELL LINE; CELL TRANSFORMATION; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; LIVER TUMOR; METABOLISM; MOUSE EMBRYONIC STEM CELL; PARACRINE SIGNALING; PATHOLOGY;

ALBUMINS; ALPHA-FETOPROTEINS; ANIMALS; ARISTOLOCHIC ACIDS; BIOMARKERS, TUMOR; CELL DEDIFFERENTIATION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; INTERLEUKIN-6; KERATIN-19; KERATIN-7; LIVER NEOPLASMS; MICE; MOUSE EMBRYONIC STEM CELLS; PARACRINE COMMUNICATION; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-MYC; SIGNAL TRANSDUCTION;

EID: 84999885215     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12424     Document Type: Article

References (32)

1. Subramaniam A, Shanmugam MK, Perumal E, Li F, Nachiyappan A, Dai X, Swamy SN, Ahn KS, Kumar AP, Tan BK, Hui KM, Sethi G. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochim Biophys Acta. 2013; 1835:46-60.
2. Tang Y, Kitisin K, Jogunoori W, Li C, Deng CX, Mueller SC, Ressom HW, Rashid A, He AR, Mendelson JS, Jessup JM, Shetty K, Zasloff M, et al. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc Natl Acad Sci U S A. 2008; 105:2445-2450.
3. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell. 2009; 139:693-706.
4. Rokavec M, Wu W, Luo JL. IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis. Mol Cell. 2012; 45:777-789.
5. Yildirimman R, Brolen G, Vilardell M, Eriksson G, Synnergren J, Gmuender H, Kamburov A, Ingelman-Sundberg M, Castell J, Lahoz A, Kleinjans J, van Delft J, Bjorquist P, et al. Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity. Toxicol Sci. 2011; 124:278-290.
6. He G, Dhar D, Nakagawa H, Font-Burgada J, Ogata H, Jiang Y, Shalapour S, Seki E, Yost SE, Jepsen K, Frazer KA, Harismendy O, Hatziapostolou M, et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell. 2013; 155:384-396.
7. Ogawa S, Tagawa Y, Kamiyoshi A, Suzuki A, Nakayama J, Hashikura Y, Miyagawa S. Crucial roles of mesodermal cell lineages in a murine embryonic stem cell-derived in vitro liver organogenesis system. Stem Cells. 2005; 23:903-913.
8. Li T, Guo MY, Ma KF, Du Y, He LY, Zhu DY, Lou YJ. [Characteristics of microsomal phase II metabolic enzymes in mouse embryonic stem cell-derived liver tissue]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013; 42:530-537.
9. Tsutsui M, Ogawa S, Inada Y, Tomioka E, Kamiyoshi A, Tanaka S, Kishida T, Nishiyama M, Murakami M, Kuroda J, Hashikura Y, Miyagawa S, Satoh F, et al. Characterization of cytochrome P450 expression in murine embryonic stem cell-derived hepatic tissue system. Drug Metab Dispos. 2006; 34:696-701.
10. Zhu DY, Du Y, Huang X, Guo MY, Ma KF, Yu YP, Lou YJ. MAPEG expression in mouse embryonic stem cell-derived hepatic tissue system. Stem Cells Dev. 2008; 17:775-783.
11. Zhu DY, Wu JY, Li H, Yan JP, Guo MY, Wo YB, Lou YJ. PPAR-beta facilitating maturation of hepatic-like tissue derived from mouse embryonic stem cells accompanied by mitochondriogenesis and membrane potential retention. J Cell Biochem. 2010; 109:498-508.
12. Simile MM, De Miglio MR, Muroni MR, Frau M, Asara G, Serra S, Muntoni MD, Seddaiu MA, Daino L, Feo F, Pascale RM. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis. 2004; 25:333-341.
13. Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M, Jung J, Gao P, Dang CV, Beer MA, Thomas-Tikhonenko A, Mendell JT. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci U S A. 2009; 106:3384-3389.
14. Arlt VM, Zuo J, Trenz K, Roufosse CA, Lord GM, Nortier JL, Schmeiser HH, Hollstein M, Phillips DH. Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice. Int J Cancer. 2011; 128:21-32.
15. Poon SL, Pang ST, McPherson JR, Yu W, Huang KK, Guan P, Weng WH, Siew EY, Liu Y, Heng HL, Chong SC, Gan A, Tay ST, et al. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Sci Transl Med. 2013; 5:101r-197r.
16. Pozdzik AA, Salmon IJ, Husson CP, Decaestecker C, Rogier E, Bourgeade MF, Deschodt-Lanckman MM, Vanherweghem JL, Nortier JL. Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol Dial Transplant. 2008; 23:2480-2491.
17. Jin K, Su KK, Li T, Zhu XQ, Wang Q, Ge RS, Pan ZF, Wu BW, Ge LJ, Zhang YH, Wang YF, Shen GF, Zhu DY, et al. Hepatic Premalignant Alterations Triggered by Human Nephrotoxin Aristolochic Acid I in Canines. Cancer Prev Res (Phila). 2016; 9:324-334.
18. Mengs U. Tumour induction in mice following exposure to aristolochic acid. Arch Toxicol. 1988; 61:504-505.
19. Thornton JE, Gregory RI. How does Lin28 let-7 control development and disease? Trends Cell Biol. 2012; 22:474-482.
20. Chiba T, Kamiya A, Yokosuka O, Iwama A. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective. Cancer Lett. 2009; 286:145-153.
21. Aterman K. Hepatic neoplasia: reflections and ruminations. Virchows Arch. 1995; 427:1-18.
22. Oka M, Moriyama T, Asally M, Kawakami K, Yoneda Y. Differential role for transcription factor Oct4 nucleocytoplasmic dynamics in somatic cell reprogramming and self-renewal of embryonic stem cells. J Biol Chem. 2013; 288:15085-15097.
23. Chen JY, Tang YA, Li WS, Chiou YC, Shieh JM, Wang YC. A synthetic podophyllotoxin derivative exerts anti-cancer effects by inducing mitotic arrest and pro-apoptotic ER stress in lung cancer preclinical models. PLoS One. 2013; 8:e62082.
24. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T, Thorgeirsson SS. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med. 2006; 12:410-416.
25. Govaere O, Komuta M, Berkers J, Spee B, Janssen C, de Luca F, Katoonizadeh A, Wouters J, van Kempen LC, Durnez A, Verslype C, De Kock J, Rogiers V, et al. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut. 2014; 63:674-685.
26. Zhang L, Mu X, Fu J, Zhou Z. In vitro cytotoxicity assay with selected chemicals using human cells to predict targetorgan toxicity of liver and kidney. Toxicol In Vitro. 2007; 21:734-740.
27. Kung JW, Currie IS, Forbes SJ, Ross JA. Liver development, regeneration, and carcinogenesis. J Biomed Biotechnol. 2010; 2010:984248.
28. Bollrath J, Greten FR. IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. Embo Rep. 2009; 10:1314-1319.
29. Zhu D, Qu L, Zhang X, Lou Y. Icariin-mediated modulation of cell cycle and p53 during cardiomyocyte differentiation in embryonic stem cells. Eur J Pharmacol. 2005; 514:99-110.
30. Seiler AE, Spielmann H. The validated embryonic stem cell test to predict embryotoxicity in vitro. Nat Protoc. 2011; 6:961-978.
31. Naito S, von Eschenbach AC, Giavazzi R, Fidler IJ. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res. 1986; 46:4109-4115.
32. Yang H, Dou Y, Zheng X, Tan Y, Cheng J, Li L, Du Y, Zhu D, Lou Y. Cysteinyl leukotrienes synthesis is involved in aristolochic acid I-induced apoptosis in renal proximal tubular epithelial cells. Toxicology. 2011; 287:38-45.